Filing Details
- Accession Number:
- 0001179110-13-008331
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-13 16:54:24
- Reporting Period:
- 2013-05-09
- Filing Date:
- 2013-05-13
- Accepted Time:
- 2013-05-13 16:54:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1427141 | Bernard William O'connor | 8 Sylvan Way Parsippany NJ 07054 | Sr Vp & Chief Acct. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-09 | 25,000 | $19.98 | 50,058 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-09 | 25,000 | $35.00 | 25,058 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-05-09 | 4,654 | $12.95 | 29,712 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-09 | 4,654 | $35.00 | 25,058 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right-to-buy) | Disposition | 2013-05-09 | 25,000 | $0.00 | 25,000 | $19.98 |
Common Stock | Option (Right-to-buy) | Disposition | 2013-05-09 | 4,654 | $0.00 | 4,654 | $12.95 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
50,000 | 2016-04-24 | No | 4 | M | Direct | |
0 | 2019-02-20 | No | 4 | M | Direct |
Footnotes
- The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. O'Connor on March 15, 2013.
- As of 5/9/2013, the original grant (100,000 shares granted on 4/24/2006) was fully vested. After the exercise of the options reported hereby, 50,000 shares covered by this option have been exercised.
- As of 5/9/2013, the original grant (4,654 shares granted on 2/20/2009) was fully vested. After the exercise of the options reported hereby, all shares covered by this option have been exercised.